美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA214860"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
72542-200-09 72542-200 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-200-09) / 1 KIT in 1 BOX (72542-200-02) * 1 FOR SUSPENSION in 1 PACKET (72542-002-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01)
72542-300-09 72542-300 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-300-09) / 1 KIT in 1 BOX (72542-300-02) * 1 FOR SUSPENSION in 1 PACKET (72542-003-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01)
72542-400-18 72542-400 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-400-18) / 1 KIT in 1 BOX (72542-400-02) * 1 FOR SUSPENSION in 1 PACKET (72542-002-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01)
72542-500-18 72542-500 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-500-18) / 1 KIT in 1 BOX (72542-500-02) * 1 FOR SUSPENSION in 1 PACKET (72542-003-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01) * 1 FOR SUSPENSION in 1 PACKET (72542-002-01)
72542-600-18 72542-600 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-600-18) / 1 KIT in 1 BOX (72542-600-02) * 1 FOR SUSPENSION in 1 PACKET (72542-003-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01)
72542-667-18 72542-667 HUMAN PRESCRIPTION DRUG OLPRUVA sodium phenylbutyrate KIT ORAL 20221222 N/A NDA NDA214860 Acer Therapeutics Inc. 90 BOX in 1 CARTON (72542-667-18) / 1 KIT in 1 BOX (72542-667-02) * 1 FOR SUSPENSION in 1 PACKET (72542-367-01) * 1 FOR SUSPENSION in 1 PACKET (72542-000-01) * 1 FOR SUSPENSION in 1 PACKET (72542-003-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase